Počet záznamů: 1  

Reprogramming of leukemic cell metabolism through the naphthoquinonic compound Quambalarine B

  1. 1.
    SYSNO ASEP0489413
    Druh ASEPJ - Článek v odborném periodiku
    Zařazení RIVJ - Článek v odborném periodiku
    Poddruh JČlánek ve WOS
    NázevReprogramming of leukemic cell metabolism through the naphthoquinonic compound Quambalarine B
    Tvůrce(i) Vališ, Karel (MBU-M) ORCID
    Grobárová, Valeria (MBU-M)
    Hernychová, Lucie (MBU-M)
    Bugáňová, Martina (MBU-M)
    Kavan, Daniel (MBU-M) RID, ORCID
    Kalous, M. (CZ)
    Černý, Jiří (BTO-N) RID, ORCID
    Stodůlková, Eva (MBU-M) ORCID
    Kuzma, Marek (MBU-M) ORCID, RID
    Flieger, Miroslav (MBU-M) ORCID
    Černý, J. (CZ)
    Novák, Petr (MBU-M) RID, ORCID
    Zdroj.dok.OncoTarget. - : Impact Journals LLC - ISSN 1949-2553
    Roč. 8, č. 61 (2017), s. 103137-103153
    Poč.str.17 s.
    Jazyk dok.eng - angličtina
    Země vyd.US - Spojené státy americké
    Klíč. slovametabolism ; leukemia ; naphthoquinones
    Vědní obor RIVEE - Mikrobiologie, virologie
    Obor OECDMicrobiology
    Vědní obor RIV – spolupráceBiotechnologický ústav - Mikrobiologie, virologie
    CEPGA13-16565S GA ČR - Grantová agentura ČR
    GP14-21095P GA ČR - Grantová agentura ČR
    ED1.1.00/02.0109 GA MŠMT - Ministerstvo školství, mládeže a tělovýchovy
    LO1509 GA MŠMT - Ministerstvo školství, mládeže a tělovýchovy
    Institucionální podporaMBU-M - RVO:61388971
    UT WOS000419562500035
    EID SCOPUS85035358010
    DOI10.18632/oncotarget.21663
    AnotaceAbnormalities in cancer metabolism represent potential targets for cancer therapy. We have recently identified a natural compound Quambalarine B (QB), which inhibits proliferation of several leukemic cell lines followed by cell death. We have predicted ubiquinone binding sites of mitochondrial respiratory complexes as potential molecular targets of QB in leukemia cells. Hence, we tracked the effect of QB on leukemia metabolism by applying several omics and biochemical techniques. We have confirmed the inhibition of respiratory complexes by QB and found an increase in the intracellular AMP levels together with respiratory substrates. Inhibition of mitochondrial respiration by QB triggered reprogramming of leukemic cell metabolism involving disproportions in glycolytic flux, inhibition of proteins O-glycosylation, stimulation of glycine synthesis pathway, and pyruvate kinase activity, followed by an increase in pyruvate and a decrease in lactate levels. Inhibition of mitochondrial complex I by QB suppressed folate metabolism as determined by a decrease in formate production. We have also observed an increase in cellular levels of several amino acids except for aspartate, indicating the dependence of Jurkat (T-ALL) cells on aspartate synthesis. These results indicate blockade of mitochondrial complex I and II activity by QB and reduction in aspartate and folate metabolism as therapeutic targets in T-ALL cells. Anti-cancer activity of QB was also confirmed during in vivo studies, suggesting the therapeutic potential of this natural compound.
    PracovištěMikrobiologický ústav
    KontaktEliška Spurná, eliska.spurna@biomed.cas.cz, Tel.: 241 062 231
    Rok sběru2019
Počet záznamů: 1  

  Tyto stránky využívají soubory cookies, které usnadňují jejich prohlížení. Další informace o tom jak používáme cookies.